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Summary
Background: Since the beginning of 2008, the implementation of a 100% activity-based payment
system, has made efﬁciency one of the prime concern for the French health-care providing
institutions. We therefore assessed the real cost of a scheduled total hip replacement (THR) in
a teaching hospital and compared ﬁndings with French national data (and with the Government
Healthcare Insurance System allowance).
Hypothesis: The study should suggest possible means to optimize organization of management
and/or clinicians’ practice.
Material and methods: This is a retrospective full-cost economic study. Patients were included
only if fulﬁlling the following criteria: admitted in 2006; classiﬁed in Diagnosis-Related Group
(DRG) 08C23V or 08C23W (respectively THR without and with associated comorbidity); treated
in a single department; admitted from home; and having undergone a THR (coded as NEKA020 in
the french CPT) that same year. Treatment-cost was established on the basis of data collected
from two main sources: the Information Systems Medicalization Program (ISMP) data-base, and
the ﬁnance department data, which were taken into account in line with the French National
Costs Study (NCS) structure.
∗ Corresponding author.
E-mail address: Christophe.segouin@lrb.aphp.fr (C. Segouin).
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remains, however, limited by the rules currently in use at each individual hospital’s accounting
department.
Level of evidence: Level IV, retrospective economic and decision analysis study.
© 2009 Elsevier Masson SAS. All rights reserved.
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Type of study and populationntroduction
s part of the ﬁnancial reform package (activity-based
unding [ABF]), French health-care establishments (medi-
al, surgical and obstetric [MSO]) are having to implement
ew managerial approaches. Notably, they need to know
heir own production costs, as they are required to draw
p an annual Provisional statement of income and expendi-
ure (PSIE). The Lariboisière—Fernand-Widal hospital group,
Paris teaching hospital, faces the same challenges as all
ther French public health-care establishments with respect
o its MSO activity.
As far as income is concerned, each admission is classi-
ed in a Diagnosis-related group (DRG) by the Information
ystems Medicalization Program (ISMP). Each DRG has a
ationally established price attributed to it (with weight-
ng in certain geographical regions), corresponding to the
ayment the establishment can receive for the stay [1].
rices are set at national level, based on the data of the
ational Costs Study (NCS), conducted by some 50 volunteer
nstitutions.
Since ABF came to be implemented across the board in
008, more than half of the income of hospitals has come
irectly from admissions.
To balance their ﬁnances, establishments also need to
orecast and, if required, control their costs. However, the
ccountancy practiced in French public health-care estab-
ishments is not such as to allow ﬁne-grained analysis of
he costs entailed by treating patients and pathologies.
here is a tool, called the Case-Mix Costs table (CMCT),
hich, according to the Hospital Expertise and Audit Mis-
ion (MEAH), ‘‘enables the MSO activity costs of a given
ealth-care establishment to be compared to a virtual
stablishment with exactly the same activity measured in
erms of DRGs but with production costs calculated from
he unit costs identiﬁed in the NCS’’ [2]. Applying this
t the level of the hospital, section or department allows
ost lines diverging from the national average to be high-
ighted. The degree of information compaction, however, is
oo high to allow clinicians to design any concrete improve-
ent plans. If, for example, costs incurred by the use of
F
c
oechnical platforms are above the national average, there
s nothing to show whether this ﬁnding concerns the whole
ange of pathologies managed in the department, section or
ospital or just certain speciﬁc pathologies. Since clinical
epartments rarely have any time to organize a review of
heir ﬁles on such a topic, such a ﬁnding will probably not
ead to anything actually being done.
The present study sought to lay the foundations for
simple, reproductible methodology for assessing total
anagement costs for a given pathology on the basis
f existing medico-administrative data. The aim was to
nable hospital departments that do not have NCS-type
nalytic accountancy to know the costs of managing the
ain pathologies they deal with and make comparisons
ith national mean values. Implementing the approach
ould ﬁrst of all enable the costs involved in the depart-
ent/hospital’s main activities to be calculated. Secondly,
he professionals concerned could then identify the cost-
ines on which marginal efﬁciency might be achieved in
erms of treatment organization. Detailed information and
omparison to national-level data form a preliminary phase
rior to reﬂection concerning treatment organization and
ractices. The ﬁnal objective is to improve efﬁciency. Such a
tudy might also improve cooperation between management
nd physicians [3].
Total hip replacement (THR) was selected as focus,
rstly, as being frequent, at about 12.9% of our ortho-
edic department’s activity in 2007 (DRG of THR with or
ithout associated comorbidity); and secondly, in the light
f population aging [4] and of our section’s specialization
n prosthetics in young patients, as offering considerable
evelopment potential.
aterial and methodsT. Lernout et al.
Results: Themethodology employed here follows the 2006 National Costs Scale structure. Treat-
ment costs (excluding the cost of implantable medical devices or IMDs) were estimated at
D 8,104.72 for DRG 08C23W and D 7,529.19 for DRG 08C23V. These ﬁgures were higher than the
rates authorized in 2006 (excluding IMDs), which were D 7,677.92 for 08C23W and D 6,358.97
for 08C23V (taking the 7% geographic coefﬁcient into account) and than the 2005 NCS ﬁgures
(excluding IMDs) of respectively D 7,536.13 and D 6,083.59.
Discussion: Clinical units and departments need to be able to assess costs for the patholo-
gies they treat, as health-care institutions have to balance their expenditure against their
income, which largely comes from their hospital-care activity. The methodology put forward
here, of cost comparison according to the NCS structure, enables the total cost to be known.
Comparing results (expenditure line by expenditure line) against national data, selectively high-
lights the areas in which efﬁciency can be improved. The exactitude of the obtained resultsor the purposes of the study, we calculated the total
ost [5] of a hospital stay, from the point of view
f the hospital. The study was retrospective, con-
ing
•
•
•Cost analysis in total hip arthroplasty: Experience of a Teach
cerning patients admitted for THR in the orthopedic
surgery department of our hospital group during the year
2006. In the 10th DRG classiﬁcation, such admissions
come under DRG 08C23V or 08C23W (respectively, ‘‘Hip
replacement without associated comorbidity’’ and ‘‘Hip
replacement with associated comorbidity’’). As this par-
ticular DRG classiﬁcation was implemented in March 2006,
the study period was limited to the last 9 months of that
year.
DRGs are meant to be homogeneous in terms of
resources, whereas there are a number of differ-
ent item codes for THR. To obtain a homogeneous
treatment cost, we therefore made the calculation
for a ‘‘standard’’ patient group, deﬁned by three
criteria:
D
T
i
Table 1 Work units (WU), data and calculation formulae per exp
Rubric WU Data
Salaries: medical staff, nurses,
auxiliaries, etc
Hospital
day (HD)
Invoicab
Personn
Maintenance amortization,
medical logistics
HD ID
Personn
Medical and non-medical theater
staff
Relative
cost index
(RCI)
Personn
N RCIs p
theater
target)
Theater
Other expenses
RCI Expendi
personn
(excl. pr
medical
logistics
N RCIs p
theater
target)
Laboratory Bio and
Path
N Bio an
requeste
target)
Imaging, functional exploration,
anesthesia + postanesthesia care
unit
RCI N RCIs r
and targ
Other medicotechnical items Other m
(excl. re
N RCIs r
and targ
Inc. rehab AMC
AMS
N AMC a
requeste
target)
Medical consumables (inc. IMDs),
drugs
Days Expendi
medical
ID
Target IM
Catering, laundry, general logistics Days Expendi
ID
Overheads Days LRB ove
expendi
LRB IDs
IDs
N: number; HD: hospital day; MSD: mean stay duration; ID: invoicab
procedures by physiotherapists; IMD: implantable medical device; IC
target: number of all patients treated and number of target populationMedical Center located in Paris 115
type of surgery: unilateral THR without replacement of
prosthesis, graft, osteotomy or reconstruction. The item
chosen for the study was thus ‘‘Hip joint replacement by
total prosthesis’’, coded NEKA020 on the 2nd version of
the Common Classiﬁcation of Medical Procedures (CCMP);
type of stay: single ward; the entire stay was within the
same medical ward;
type of admission: patients admitted from Emergency or
by transfer were excluded, and only those admitted from
home (‘‘Home Admission Mode’’) were included.ata collection
he study data-base was constructed from 3 computer-
zed data-bases of the Paris Hospitals Board (Assistance
enditure-line (NCS model) (excl. blood products).
Means of calculating mean stay cost
le day (ID)
el expenditure
(expenditure/n ID)×MSD Finances
el expenditure
el expenditure
roduced by
(total and
(expenditure/total RCI)× target RCI
ture on
el, operating
osthesis),
acts, medical
, gen. logistics.
roduced by
(total and
d Path tests
d (total and
(IC/total B or P)× (target Bio or Path)
equested (total
et)
(IC/total RCI)× target RCI
edical services
hab)
equested (total
et)
(IC/total RCI)× target RCI
nd AMS
d (total and
(IC/total AMC +AMS)× (target target)
ture on drugs,
consumables
D expenditure
(expenditure/n ID)×MSD Finances
ture per post (expenditure/n ID)×MSD Finances
rheads
ture
(expenditure LRB/n ID for all
LRB)×MSD Finances
le day; RCI: relative cost index; AMC and AMS: refer to rehab
: induced charges (induced in one dept by another); total and
patients treated; LRB: Lariboisière.
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ublique—Hôpitaux de Paris [AP—HP]): administrative data
n hospital patients (GILDA© identity server), medical pro-
edures performed while in hospital (AR CCAM® total
rocedures server), and ward reports (SIMPA© grouper).
Financial data on expenditure by the hospital group and
he AP-HP were edited, for 2006, by the Financial Affairs
epartment of the AP-HP.
alculation of hospital stay costs
he two DRGs were distinguished for purposes of cost calcu-
ation. The itemization was that used in the 2005 National
osts Study, as found in the present Results Tables. This
eans that catering, laundry and maintenance costs were
ncluded, unlike in many other studies of hospital stay costs
6,7,8].
Patients were admitted to the orthopedics department
nd managed in the in-patients ward and in theater. Costs
or both of these sectors were analyzed, and calculated by
he most appropriate Work Unit (WU). Table 1 presents the
Us, the data and the calculation for each cost item. Cost
er day was calculated in terms of the number of invoica-
le administrative hospitalization days (used for ﬁnancial
ata), so that the data would be homogeneous. Thus, each
‘ISMP’’ stay duration was increased by 1 day to obtain the
dministrative stay duration.
Certain NCS cost-lines were not used in the study: obstet-
ic theater, dialysis, Emergency and mobile emergency and
obile intensive care unit (SMUR), intensive care, and exter-
al procedure costs. Our target cases were non-emergency
ingle ward stays, and there was thus no involvement of
epartments other than orthopedics.
Results for the 2 DRGs were compared to the costs given
y the NCS and the rates applied by the French National
ealth Insurance scheme (CPAM).
esultsarget population
n all, 57 admissions under DRG 08C23V and 72 under
8C23W were included (Fig. 1).
igure 1 Target population with (08C23V) and without
08C23W) comorbidity for scheduled THR admission in 2006.
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ost of care in the hospital group and comparison
o NCS values
esults are shown in Tables 2 and 3. The monetary unit is
he Euro. Care costs were D 7,529.19 for DRG 08C23V and
8,104.72 for DRG 08C23W, excluding the IMDs. Comparison
ith NCS data revealed the following differences:
the mean hospital stay was shorter than in the NCS, for
both DRG 08C23V and DRG 08C23W (respectively, 8.8 vs
12.6 and 9.3 vs 16.9 days). According to type of discharge,
mean stay was 2 days longer for patients referred to a
rehabilitation center (42% of patients) than for those dis-
charged home. Even in case of rehabilitation referral,
mean stays were still shorter than in the NCS: respec-
tively, 10.3 and 10.0 days for DRGs 08C23V and 08C23W;
mean cost per patient was lower (by > 5%) than in the NCS
in three areas: personnel, imaging and overheads;
mean catering and laundry costs per patient were compa-
rable to NCS values for DRG 08C23W, as were mean
catering and general logistics costs for DRG 08C23V, while
overheads costs were lower for both;
in contrast, mean medical logistics costs per patient (line
5) were signiﬁcantly higher than in the NCS; smaller dif-
ferences were also found for theater costs (line C) and
‘‘Total medico-technical’’ costs (line D);
ﬁnally, there was a difference of 15% or 25% (respectively,
for DRGs 08C23W and 08C23V) for consumables, medica-
tion and blood costs (line E).
Thus, care costs for our target DRGs (08C23W and
8C23V) were higher than those found in the NCS and than
he CPAM rate after application of the geographic coefﬁ-
ient.
iscussion
ethodology
he methodology used to calculate care costs was based
n the cost-structure of the 2005 French National Costs
cale. A Medline review was carried out in June 2008,
sing the MeSH keywords ‘‘Arthroplasty, Replacement’’,
‘Cost and Cost Analysis’’, and ‘‘Arthroplasty, Replacement,
ip/economics’’, to compare our methodology to others. It
ound no published studies with detailed calculation of total
ospital THR management costs. Chamberlin et al. [6] deter-
ined the direct hospital cost of managing pertrochanteric
racture in the elderly, and Stargart [9] assessed differ-
ntial primary THR costs across 9 EU member countries,
ut with insufﬁcient methodological detail for comparison
ith the present results. Finally, the Rhône-Alpes Regional
nion of Private Physicians (URMLRA) in France compared
osts between three surgical procedures [10]. All in all,
hether before or after the introduction of ABF, few such
tudies have been published. [4,5], although some of the
ost-calculation methods presented in the above-mentioned
EAH report do show certain similarities to ours.
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Table 2 Full unit cost (Euros) of DRG 08C23W in 2006.
Lariboisière (NEKA 020) NCS 2005a Diff. HG/NCS
HG expenditure
NCS (expenditure)/NCS
(expenditure)
Number of admissions or
sessions
72 Number of admissions or
sessions
1 365
Lariboisière ISMP MSD
(days)
9.3 NCS MSD (days) 16.9
MSD Finance (days) 10.3 NCS IC stay (days) 0.1
Mean age (years) 63.7
1 Medical staff salaries 138.41 Medical staff salaries 376.14 −63%
2 Nurse + auxiliaries
salaries
1565.68 Nurse salaries (inc.
auxiliaries)
1699.60 −8%
3 Other salaries 332.71 Other salaries 431.47 −23%
A =1 +2 +3 Total personnel 2036.80 Total personnel 2507.21 −19%
4 Maintenance
amortization
18.18 Maintenance
amortization
20.74 −12%
5 Medical logistics 576.84 Medical logistics 118.23 388%
B =4 +5 Maintenance
Amortization+medical
Logistics
595.02 Maintenance
Amortization+medical
Logistics
138.97 328%
6 Medical theater staff 234.65 Theater staff 682.04 −9%
7 Non-medical theater
staff
384.10
8 Other theatre
expenditure
1228.64 Other theatre
expenditure
404.71 204%
C =6 +7 +8 Total theater 1847.38 Total theater 1086.75 70%
9 Lab 517.82 Lab 253.18 105%
10 Obstetric theater 0.00 Obstetric theater 0.91 NA
11 Imaging 44.99 Imaging 117.44 −62%
12 Functional exploration 3.32 Functional exploration 20.79 −84%
13 Dialysis 0.00 Dialysis 21.07 NA
14 Anesthesia + postanesthesia
care unit
853.02 Anesthesia + postanesthesia
care unit
682.30 25%
15 Emergency 0.00 Emergency 41.11 NA
16 SMUR 0.00 SMUR 5.41 NA
17 X-ray 0.00 X-ray 2.45 NA
18 IC IC 139.95 NA
19 Other medico-technical 472.17 Other medico-technical 58.33 709%
inc. rehab 472.17
118
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Table 2 (Continued )
Lariboisière (NEKA 020) NCS 2005a Diff. HG/NCS
HG expenditure
NCS (expenditure)/NCS
(expenditure)
D =9 to 19 Total medico-technical
procedures
1891.32 Total medico-technical
procedures
1342.94 41%
Medical consumables
(inc. IMDs)
1769.99 Medical consumables
(inc. IMDs)
1117.74
Blood products Blood products 250.75
Drugs Drugs 173.98
E Total consumables,
drugs, blood
1769.99 Total consumables,
drugs, blood
1542.48 15%
20 External procedures External procedures 60.46
I =A to E +20 Total ‘‘medical’’ cost 8140.51 Total ‘‘medical’’ cost 6678.79 22%
II Catering 226.92 Catering 209.71 8%
III Laundry 78.54 Laundry 84.45 −7%
IV General logistics 1182.71 General logistics 1374.65 −14%
V Overheads 246.02 Overheads 306.26 −20%
Total cost inc.
Overheads
9874.71 Total cost inc.
Overheads
8653.87 14%
Total cost inc.
Overheads, excl. IMD
8104.72 Total cost inc.
Overheads, excl. IMD
7536.13 7.5%
MSD: mean stay duration; IMD: implantable medical device; NCS: national costs scale; DRG: diagnosis-related group; HG: hospital group; SMUR: Mobile intensive care team (service mobile
d’urgence et de réanimation); IC: induced charges (induced in one dept by another).
a The 2005 National Costs Scale was used, as it set rates for 2006.
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Table 3 Full unit cost (Euros) of 08C23V in 2006.
Lariboisière (NEKA 020) NCS 2005a Rapport GH/ENC
Dépenses (GH)
Dépenses (ENC)/(Dépenses
ENC)
Number of admissions or
sessions
57 Number of admissions or
sessions
7069
Lariboisière ISMP MSD
(days)
8.8 NCS MSD (days) 12.6
MSD Finance (days) 9.8 NCS IC stay (days) 1.1
Mean age (years) 62.7
1 Medical staff salaries 131.70 Medical staff salaries 263.50 −50%
2 Nurse + auxiliaries
salaries
1489.68 Nurse salaries (inc.
auxiliaries)
1426.38 4%
3 Other salaries 316.56 Other salaries 362.58 −13%
A =1 +2 +3 Total personnel 1937.93 Total personnel 2052.46 -6%
4 Maintenance
amortization
17.29 Maintenance
amortization
14.38 20%
5 Medical logistics 548.84 Medical logistics 97.34 464%
B =4 +5 Maintenance
amortization +medical
logistics
566.13 Maintenance
amortization +medical
logistics
111.72 407%
6 Medical theater staff 230.27 Theater staff 628.80 −3%
7 Non-medical theater
staff
376.93
8 Other theatre
expenditure
1205.72 Other theatre
expenditure
356.70 238%
C =6 +7 +8 Total theater 1812.92 Total theater 985.50 84%
9 Lab 323.74 Lab 149.38 117%
10 Obstetric theater 0.00 Obstetric theater 0.00 NA
11 Imaging 41.43 Imaging 79.30 −48%
12 Functional exploration 0.89 Functional exploration 7.80 −89%
13 Dialysis 0.00 Dialysis 0.17 NA
14 Anesthesia + postanesthesia
care unit
745.21 Anesthesia + postanesthesia
care unit
579.01 29%
15 Emergency 0.00 Emergency 25.90 NA
16 SMUR 0.00 SMUR 2.03 NA
17 X-ray 0.00 X-ray 1.37 NA
18 IC 0.00 IC 7.18 NA
19 Other medico-technical 450.92 Other medico-technical 40.44 1015%
Inc. rehab 450.92
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Table 3 (Continued )
Lariboisière (NEKA 020) NCS 2005a Rapport GH/ENC
Dépenses (GH)
Dépenses (ENC)/(Dépenses
ENC)
D =9 to 19 Total medico-technical
procedures
1 562.20 Total medico-technical
procedures
892.58 75%
Medical consumables
(inc. IMDs)
1865.73 Medical consumables
(inc. IMDs)
1222.14
Blood products Blood products 185.25
Drugs Drugs 85.01
E Total consumables,
drugs, blood
1865.73 Total consumables,
drugs, blood
1492.40 25%
20 External procedures External procedures 29.41
I =A to E +20 Total ‘‘medical’’ cost 7744.91 Total ‘‘medical’’ cost 5564.07 39%
II Catering 215.90 Catering 182.58 18%
III Laundry 74.73 Laundry 69.83 7%
IV General logistics 1 125.30 General logistics 1 187.55 −5%
V Overheads 234.08 Overheads 256.70 −9%
Total cost inc.
Overheads
9394.92 Total cost inc.
Overheads
7260.73 29%
Total cost inc.
Overheads, excl. IMD
7529.19 Total cost inc.
Overheads, excl. IMD
6083.59 24%
MSD: mean stay duration; IMD: implantable medical device; NCS: national costs scale; DRG: diagnosis-related group; HG: hospital group; SMUR: Mobile emergency team (service mobile
d’urgence et de réanimation); IC: induced charges (induced in one dept by another).
a The 2005 National Costs Scale was used, as it set rates for 2006.
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Results
The cost differentials found here may have several causes.
Firstly, we included only a certain number of the patients
falling under our target DRGs. There are also other possible
causes, which we shall examine by cost-sector.
Medical staff expenditure in the ward
The difference observed here is due to the combination
of two factors. The ﬁrst concerns how time is shared out
between theater, consultations and the in-patients depart-
ment. In our institution, each head of department draws
up this distribution yearly for accountancy purposes, and
it is not then objectiﬁed by any precise measurement of
work-time spent on practitioners’ various activities. More-
over, in this teaching hospital, the department is staffed
by university-employed physicians, who cost the institution
less than hospital-employed practitioners would: the hos-
pital itself pays a university professor less than 60% of the
salary it pays to a full-time hospital practitioner.
Medical expenditure (laboratory, imaging and
consumables)
The total laboratory cost differential may have been due to
the number of laboratory acts being higher than the national
average, or to higher production costs. It therefore has to
be determined whether this was a volume effect or a price
effect. If it was a volume effect or prescriber effect (e.g.,
trainee physicians), this needs discussing with the clinicians
as it is a question of practices. Imaging costs, in contrast,
were half those of the NCS, for which there are two possi-
ble explanations. The available NCS data fail to distinguish
between scheduled THR costs and those for THR secondary
to fracture, which require more X-ray items. Moreover, X-
ray production costs may be lower in our institution than
in the NCS institutions, or again our department’s protocol
may entail fewer X-rays. These points are currently under
study.
Finally, the cost differential in consumables, drugs and
blood products (line E) may be due to the use of speciﬁc
and more costly IMDs for younger patients (63.7 and 62.7
years, respectively for DRGs 08C23W and 08C23V). It is to
be noted that lack of available accountancy data prevented
our costing the blood products actually used for the study
patients; a mean cost for orthopedic department patients
as a whole was used instead.
Other expenditure
The signiﬁcant difference in medical logistics costs (line 5)
compared to the NCS values may be due to how they are
apportioned by AP—HP HQ, so that catering, laundry, gen-
eral logistics and overheads vary from one establishment to
another. On-going amortization of a new sterilization system
may also enter into this differential.
The theater costs differential (line C) may correspond to
a signiﬁcant potential for productivity gains by optimizing
theater occupation (as conﬁrmed by a subsequent audit).
Moreover, our accounting procedure included theatre logis-
tics under the WU ‘‘relative cost index’’ (RCI), although this
was inappropriate to the deﬁnition of RCI as the accountancy
WU for medico-technical procedures. The RCI represents
p
s
o
t
bMedical Center located in Paris 121
he human and material resources directly deployed in each
CMP procedure [11]. Our choice was due to the presence of
uch lines in the analytic accounts system we had available.
oreover, our analytic accounts system fails fully to distin-
uish IMDs paid for as extras (nails, cement, etc.), which may
ave increased the mean RCI cost. Furthermore, the signiﬁ-
ant difference in medico-technical procedure costs (line D)
ay be due to our having included rehabilitation procedures
nder line 19 (‘‘Other medico-technical’’) rather than line
(personnel expenditure).
Not all cost analyses take account of general expendi-
ure [6,7,8], although a useful database for this exists (the
ngers data-base). Some studies, moreover, do not include
calculation of investment and amortization costs [8]. We
hose to take these on board, as the PSIE was drawn up
ith these two elements taken into account. However, the
peciﬁcity of the AP—HP, of which our hospital group is a
art, must be borne in mind: HQ costs are spread over the
6 institutions making up the AP—HP. Expenses reduced to
he ‘‘day of hospital stay’’ WU are strongly affected by the
uration of the stay. The present mean stay durations were
horter than in the NCS and may mask mean daily stay costs
hat were higher. Also, the difference in mean stay duration
ccording to type of discharge (home or rehab center) is
orth examining in a dedicated study: the present research
id not distinguish the two, and the issue is being addressed
s part of the clinical trajectory analysis being undertaken
n the orthopedics department at the time of writing.
Finally, the total costs for the two DRGs were almost
dentical, whereas 08C23W might have been expected to be
ore costly. Several hypotheses would be worth exploring,
otably the relatively short duration of stays for 08C23W in
ur institution, despite perfectly standard management (the
xactitude of the DRG coding having been double-checked).
urther information will be needed in order to guide action.
nterest of the study
orking from existing data, we sought to determine the cost
f a procedure that is homogeneous and frequent in our
nstitution. Comparison between our calculated costs and
hose of the NCS and the CPAM rate [11] revealed certain
ifferences. These ﬁndings, in turn, lead us to explore the
easons for such differences, in close collaboration with the
epartments concerned, whether administrative, medico-
echnical or clinical.
The approach by cost-line helps target corrective action
s part of the orthopedic department’s quest for efﬁciency.
mproved patient management should help optimize costs;
reater awareness of the interest of early standing and
he precautions to be taken by the care-team, or again
replanned and more frequent intervention by physiother-
pists, should combine to reduce mean hospital stay. This
ould reduce those costs that are directly bound to stay
uration. Moreover, this activity-based rather than DRG-
ased approach is closer to that of the clinician, enabling
hysicians to be more actively involved in the search for
olutions. This kind of approach may help guide the choice
f issues in the assessment of professional practices: e.g.,
he relevance of prescribing complementary imaging and
iological examinations.
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Drawing up ‘‘clinical trajectories’’ [12] could help opti-
ize management. Depending on the presenting pathology,
patient’s care-trajectory within the establishment is
etermined as of admission. This presenting pathology, how-
ver, is not the sole relevant factor, as possible comorbidity
nd medico-psycho-social factors inﬂuence the indications
or procedures and expert involvement along the trajectory,
ll of which impact stay duration. Such factors need to be
aken into account at admission.
The study had the virtue of promoting a genuine part-
ership between the Public Health and Health Economics
epartment, the clinical department and the Finance
epartment, and this at a time when efﬁciency is being
xplicitly required of health-care establishments by the
uthorities. This work needs reﬁning, with more precise cal-
ulation of personnel and consumables costs, which it is
ossible to detail per patient.
tudy limitations
n the terms of the review of the medico-economic literature
onducted by Bozic et al. [13], the present study corre-
ponds to the 58% of cost-identiﬁcation studies and the 80%
arried out from the point of view of the establishment. The
esults are to be taken with caution, as tendencies. Unlike
ertain cost analyses, we did not calculate either the hourly
osts of medical and paramedical staff [11] and their distri-
ution between theater and ward or exact costs for medical
onsumables and imaging [6,7,14] or laboratory examina-
ions for target patients. It is worth noting that medical and
aramedical activities are concentrated in the days directly
ollowing surgery. In other words, THR costs are not evenly
pread over the stay. The Work Unit chosen for personnel
osts in the present study is thus open to reﬂection. More-
ver, the distribution of medical personnel costs between
heater and ward depends on the distribution of medical
ersonnel’s work-time between the various sectors (consul-
ation, theater and ward), which is self-reported.
The study was also based on data for activities as coded
y the physicians themselves. The quality of this information
epends upon exactitude and thoroughness of the coding. In
006, the thoroughness of ISMP coding reached 100% in the
rthopedics department.
Moreover, not all cases classiﬁed under the two DRGs
ere analyzed. Only ‘‘single department’’ stays were
ncluded, so as to have precise costs for the orthope-
ics department (theater and ward) alone, cost distribution
eing more complicated when patients change departments
uring their stay. Likewise, non-scheduled admissions were
xcluded, and their costs may tend to be higher. And ﬁnally,
he DRGs 08C23V and 08C23W were set up in March 2006,
o that our studied concerned only the last 9 months of
hat year. All of these choices, however, had the advantage
f analyzing costs on well-deﬁned and homogeneous care
rocedures.ifﬁculties encountered
any difﬁculties can be expected during costs analysis,
specially if the institution is not involved in the National
osts Study or does not practice ﬁne-grained accountancy.T. Lernout et al.
he ﬁrst is to relate data on activity and on expenditure
hen the ISMP and ﬁnances are not cut up in the same
ay. Also, for certain items, our hospital group is dependent
n how the AP-HP spreads its costs. Finally, some technical
ifﬁculties were encountered in using the various software
rograms, which leads us to call for using a single integrated
ackage for all aspects of patient management.
onclusion
ctivity-based funding means that public health-care
stablishments need to evolve from expenditure-control
anagement to cost-control management. Given the
ational rate applied to each stay, establishments need to
now their production cost, at least for their main activi-
ies (in terms of volume and/or resources deployed), and
specially those for which efﬁciency might be improved. The
resent study was conducted with this in mind. It is then up
o those involved to work together with efﬁciency as their
im. We were able to highlight differentials with respect to
ational averages, excluding IMDs (7.5% in 08C23W and 24%
n 08C23V). The 7% differential with respect to the weighted
PAM rate (respectively −2% and −5.5%) was better, but
oo slight to be interpretable, given the above-mentioned
tudy limitations. We are all too well aware of the fact
hat the lack of precise analytic accountancy data and the
pproximations which that imposed on us precludes any
lear assertion as to whether THR costs in our hospital group
re higher or lower than the national average, especially as
egards the heavier cases classiﬁed as 08C23W. The present
tudy did, however, manage to raise a certain number of
uestions, highlighting the complexity of assessing treat-
ent costs. Our hospital group has decided to take part in
he NCS, which should help provide more useful information.
he study also helped identify points to which special atten-
ion should be paid in order to set up a process to improve
HR patient management. It has been decided to draw up a
linical THR trajectory. This will be followed by a new costs
nalysis, to assess what progress has been made.
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lossary
erms for cost analysis in common use in France ABR: activity-
based rates (tariﬁcation à l’activité: T2A)
P-HP: Assistance publique—Hôpitaux de Paris: Paris Teaching Hos-
pitals Administrative Trust
CMP: Common Classiﬁcation of Medical Procedures (Classiﬁcation
commune des actes médicaux: CCAM) equivalent to Common
Procedural Terminology (CPT)
MCT: case-mix costs table
PAM: Caisse primaire d’assurance maladie: French National Health
Insurance Third-Party Payer
RG: diagnosis-related group (groupe homogène de malades: GHM)
MD: implantable medical device
SMP: Information Systems Medicalization Program (Programme de
médicalisation des systèmes d’information: PMSI)
SO: medical—surgical—obstetric
CS: National Costs Study/National Costs Scale (Étude/Échelle
nationale de coût: ENC)
SIE: provisional statement of income and expenditure (état prévi-
sionnel de recettes et de dépenses: EPRD)
CI: relative cost indexCare Unit
HR: total hip replacement
U: work unit (unité d’œuvre)
